These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 6371871

  • 1. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W, Boisvert D, Bradwejn J.
    Psychopharmacol Bull; 1984; 20(1):108-9. PubMed ID: 6371871
    [No Abstract] [Full Text] [Related]

  • 2. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC, Kennedy NM, Gribbon D.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [Abstract] [Full Text] [Related]

  • 3. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W.
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [Abstract] [Full Text] [Related]

  • 4. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia].
    Ushakov IuV, Kravchenko NE, Kopeĭko GI, Kalugina LI, Mirzoian MG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990 Jul; 90(7):99-104. PubMed ID: 1979463
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 12. Side effects during long-term treatment with depot antipsychotic medication.
    Cookson JC.
    Clin Neuropharmacol; 1991 Jul; 14 Suppl 2():S24-30; discussion S30-2. PubMed ID: 1751940
    [Abstract] [Full Text] [Related]

  • 13. A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Winter K, Fullerton AG, Hussain K, Tarlo L.
    Br J Clin Pract; 1973 Oct; 27(10):377-80. PubMed ID: 4601614
    [No Abstract] [Full Text] [Related]

  • 14. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia.
    Leong OK, Wong KE, Tay WK, Gill RC.
    Singapore Med J; 1989 Oct; 30(5):436-40. PubMed ID: 2575796
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial].
    Woggon B, Dick P, Fleischhauer HJ, Gmür M, Gruber G, Angst J, Heimann H.
    Int Pharmacopsychiatry; 1977 Oct; 12(4):193-209. PubMed ID: 22515
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
    Wiles DH, McCreadie RG, Whitehead A.
    Psychopharmacology (Berl); 1990 Oct; 101(2):274-81. PubMed ID: 2349370
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience with fluphenazine decanoate in the treatment of patients with long-standing chronic schizophrenia.
    Christodoulidis H, Frangos H.
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):193-8. PubMed ID: 809234
    [No Abstract] [Full Text] [Related]

  • 18. Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings].
    Rifkin A, Quitkin F, Kane J, Klein DF.
    Psychopharmacol Bull; 1977 Apr; 13(2):49-50. PubMed ID: 323910
    [No Abstract] [Full Text] [Related]

  • 19. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
    Odejide OA, Aderounmu AF.
    J Clin Psychiatry; 1982 May; 43(5):195-6. PubMed ID: 7076630
    [Abstract] [Full Text] [Related]

  • 20. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics.
    Hall WB, Vestre ND, Schiele BC, Zimmermann R.
    Dis Nerv Syst; 1968 Jun; 29(6):405-8. PubMed ID: 4877748
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.